[Cardiopulmonary bypass and blood coagulation].
Kitaguchi
K
K
Furuie
H
H
D000925:Anticoagulants / Q000008:administration & dosage / Q000494:pharmacology; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000209:etiology; D001779:Blood Coagulation Factors / Q000378:metabolism; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology; D006494:Heparin Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D019763:Heparin Lyase / Q000494:pharmacology; D006801:Humans; D007035:Hypothermia / Q000209:etiology; D011183:Postoperative Complications; D011479:Protamines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D006494:Heparin Antagonists; D011479:Protamines; D006493:Heparin; D019763:Heparin Lyase